Thyroid News

In a series of thyroid nodules from adults in Ireland, the false-negative rate of an initial benign thyroid fine-needle aspiration was low, around 1%, suggesting that routine second fine-needle aspiration biopsy may not be needed.

Inpatients who are undertreated for hypothyroidism are more likely to be hospitalized longer and have a higher risk for readmission than those with normal thyroid-stimulating hormone levels, according to study findings.

Among women with infertility, those using progesterone may have a higher risk for developing thyroid cancer compared with those who have never used progesterone, although the risk remains low, according to study results.

A new study has found an increase in thyroid cancer incidence rates over a 30-year period in many countries, including the United States and several countries in the European Union.

The prevalence of hypothyroidism — overt and subclinical — is higher among women during the late menopause transition and postmenopause compared with premenopause, according to study findings.

Results of a small pilot study showed that impaired cognition was common in adults with hypothyroidism and linked to lower serum calcium levels and higher serum phosphate levels.

From 2000 to 2018, use of radioactive iodine therapy in papillary thyroid cancer treatment greatly declined in favor of total thyroidectomy alone without radioactive iodine or lobectomy, according to study data.

Adults with thyroid eye disease and diabetes have a higher prevalence of diplopia, strabismus and sight-threatening disease compared with those without diabetes, according to study findings published in Endocrine Practice.

A follow-up strategy without radioiodine appeared noninferior to an ablation strategy with radioiodine among patients with low-risk thyroid cancer undergoing thyroidectomy, according to study results in The New England Journal of Medicine.

Most children who undergo image-guided radiofrequency ablation for treatment of benign nonfunctional thyroid nodules have at least a 50% reduction in nodule volume 4 years after treatment, according to study data published in Thyroid.